![Targeting the signaling in Epstein–Barr virus-associated diseases: mechanism, regulation, and clinical study | Signal Transduction and Targeted Therapy Targeting the signaling in Epstein–Barr virus-associated diseases: mechanism, regulation, and clinical study | Signal Transduction and Targeted Therapy](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41392-020-00376-4/MediaObjects/41392_2020_376_Fig3_HTML.png)
Targeting the signaling in Epstein–Barr virus-associated diseases: mechanism, regulation, and clinical study | Signal Transduction and Targeted Therapy
![Sustained elevation of Epstein–Barr virus antibody levels preceding clinical onset of nasopharyngeal carcinoma | British Journal of Cancer Sustained elevation of Epstein–Barr virus antibody levels preceding clinical onset of nasopharyngeal carcinoma | British Journal of Cancer](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fsj.bjc.6603609/MediaObjects/41416_2007_Article_BF6603609_Fig1_HTML.jpg)
Sustained elevation of Epstein–Barr virus antibody levels preceding clinical onset of nasopharyngeal carcinoma | British Journal of Cancer
![PDF] Serological diagnosis of Epstein-Barr virus infection: Problems and solutions. | Semantic Scholar PDF] Serological diagnosis of Epstein-Barr virus infection: Problems and solutions. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/c88ae3042eb1033e8b26b83c85388f1ba6de4c95/3-Table2-1.png)
PDF] Serological diagnosis of Epstein-Barr virus infection: Problems and solutions. | Semantic Scholar
![What is EBV Ab VCA, IgM? High and low values | Lab results explained – HealthMatters.io – Lab results explained What is EBV Ab VCA, IgM? High and low values | Lab results explained – HealthMatters.io – Lab results explained](https://healthmattersio.files.wordpress.com/2019/06/ebv-ab-vca-igm.png?w=1200)
What is EBV Ab VCA, IgM? High and low values | Lab results explained – HealthMatters.io – Lab results explained
![Frontiers | High Levels of Epstein–Barr Virus Nuclear Antigen-1-Specific Antibodies and Infectious Mononucleosis Act Both Independently and Synergistically to Increase Multiple Sclerosis Risk Frontiers | High Levels of Epstein–Barr Virus Nuclear Antigen-1-Specific Antibodies and Infectious Mononucleosis Act Both Independently and Synergistically to Increase Multiple Sclerosis Risk](https://www.frontiersin.org/files/Articles/500363/fneur-10-01368-HTML/image_m/fneur-10-01368-t001.jpg)
Frontiers | High Levels of Epstein–Barr Virus Nuclear Antigen-1-Specific Antibodies and Infectious Mononucleosis Act Both Independently and Synergistically to Increase Multiple Sclerosis Risk
![Prevalence of anti-Epstein-Barr virus (EBV) IgG viral capsid antigen... | Download Scientific Diagram Prevalence of anti-Epstein-Barr virus (EBV) IgG viral capsid antigen... | Download Scientific Diagram](https://www.researchgate.net/publication/338427960/figure/fig1/AS:855981323997191@1581093259812/Prevalence-of-anti-Epstein-Barr-virus-EBV-IgG-viral-capsid-antigen-VCA-antibody.png)
Prevalence of anti-Epstein-Barr virus (EBV) IgG viral capsid antigen... | Download Scientific Diagram
![SciELO - Brasil - Prevalence of Epstein-Barr virus antibodies in healthy children and adolescents in Vitória, State of Espírito Santo, Brazil Prevalence of Epstein-Barr virus antibodies in healthy children and adolescents in SciELO - Brasil - Prevalence of Epstein-Barr virus antibodies in healthy children and adolescents in Vitória, State of Espírito Santo, Brazil Prevalence of Epstein-Barr virus antibodies in healthy children and adolescents in](https://minio.scielo.br/documentstore/1678-9849/kVYBrMLtNZjSnfw5bPfr4rF/943142e3d09bff63e1f1877f9bfeb3c16dca4089.gif)
SciELO - Brasil - Prevalence of Epstein-Barr virus antibodies in healthy children and adolescents in Vitória, State of Espírito Santo, Brazil Prevalence of Epstein-Barr virus antibodies in healthy children and adolescents in
![Targeting the signaling in Epstein–Barr virus-associated diseases: mechanism, regulation, and clinical study | Signal Transduction and Targeted Therapy Targeting the signaling in Epstein–Barr virus-associated diseases: mechanism, regulation, and clinical study | Signal Transduction and Targeted Therapy](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41392-020-00376-4/MediaObjects/41392_2020_376_Fig1_HTML.png)